Stay updated on VRDN 001 Safety and Efficacy in TED Clinical Trial

Sign up to get notified when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VRDN 001 Safety and Efficacy in TED Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The displayed site revision was updated from v3.7.1 to v3.7.2 on an otherwise unchanged 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T21:53:21.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0; the page remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-10T21:55:29.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with a minimal error screen and navigation, indicating the page is inaccessible.
    Difference
    0.5%
    Check dated 2026-09-26T21:37:21.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown for the study record, replacing the usual content with an access-denied message. This indicates restricted access to the page rather than an update to study information.
    Difference
    18%
    Check dated 2026-09-19T20:59:25.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, signaling a minor administrative update to the study record and its documentation. This change does not modify the substantive study details such as endpoints, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-08-29T18:56:05.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Results have been posted for the THRIVE study (NCT05176639), with a new 'Results Posted' entry dated 2026-08-13. The page now includes associated study documents describing veligrotug efficacy and safety outcomes.
    Difference
    3%
    Check dated 2026-08-15T20:05:58.000Z thumbnail image

Stay in the know with updates to VRDN 001 Safety and Efficacy in TED Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VRDN 001 Safety and Efficacy in TED Clinical Trial page.